Hyperion Therapeutics, Inc.

Robbins Arroyo LLP Is Investigating the Officers and Directors of Hyperion Therapeutics, Inc. (HPTX) on Behalf of Shareholders

Robbins Arroyo LLP is investigating whether certain officers and directors of Hyperion Therapeutics, Inc. (NasdaqGS: HPTX) breached their fiduciary duties to shareholders. Hyperion is a commercial biopharmaceutical company focused on the development and commercialization of therapeutics to treat disorders affecting the liver, gallbladder, biliary tree, pancreas, as well as orphan diseases.

Hyperion Announces Collusion between Andromeda Biotech, Ltd. Employees and Third-Party Biostatistics Firm

On September 8, 2014, Hyperion revealed that it is terminating the development of DiaPep277, used for treating newly diagnosed Type 1 diabetes patients, due to misconduct by recently acquired, Andromeda Biotech, Ltd. employees. Hyperion announced that it had uncovered evidence that indicates certain Andromeda employees colluded with a third party biostatistics firm to share and examine un-blinded data from the DIA-AID 1 and the ongoing DIA-AID 2 trial. Andromeda employees then used this shared data to manipulate the analyses to obtain favorable results in the DIA-AID 1 trial.

Hyperion Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.

 

Shareholder Information

Items marked with an asterisk (*) are required information. 
E-mail *Confirm: E-mail *

First Name * Last Name *
Address City State/Province *
ZIP/Postal Code Country/Region Phone *

 

Shares Purchased:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

 

Shares Sold:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:
 

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* I have read the disclaimer information
+=

    Send This Post

    Tags: